Strategies for Expediting Clinical Trials in the Next Public Health Emergency

Boghuma K. Titanji, David R. Boulware, Rachel A. Bender Ignacio

Research output: Contribution to journalShort surveypeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)E233191
JournalJAMA Health Forum
Volume4
Issue number9
DOIs
StatePublished - Sep 29 2023

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: Dr Titanji reported grants from the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program (75% salary support) and Emory Center for AIDS Research (research and salary support) during the submitted work. Dr Boulware reported serving as trial steering committee cochair for the National Institutes of Health ACTIV-6 trial focused on assessing repurposed outpatient COVID-19 therapies. Dr Bender Ignacio reported grants from National Institutes of Health; research funding through institution from Novartis, Enanta Pharmaceuticals, Ascentage Pharma; and personal fees (consulting) from Resverlogix outside the submitted work.

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this